Biological Markers of Diabetes Mellitus (Ongoing)

Posted On 2020-08-18 13:56:00



This Series on “Biological Markers of Diabetes Mellitus” is edited by Dr. Alexander E Berezin from Ministry of Health of Ukraine (Ukraine) and Dr. Leonardo Roever from Federal University of Uberlndia (Brazil).

Alexander E. Berezin, MD, PhD
Therapeutic Unit, Internal Medicine Department, State Medical University of Zaporozhye, Zaporozhye, Ukraine;
Therapeutic Department, Private Hospital “Vita-Center”, Zaporozhye, Ukraine

Dr. Alexander E. Berezin has received PhD in 1994 in the State Medical University of Zaporozhye (Ukraine). He is currently working as a Professor of Medicine at the State Medical University of Zaporozhye (Ukraine).

He is a fellow of the Ukrainian Cardiology Association; Member of the Ukrainian Heart Failure Association; Member of Heart Failure Association of the ESC; Member of European Acute Cardiovascular Care Association; Member of W.G. on Atherosclerosis and Vascular Biology of the ESC; Member of European Association of Percutaneous Cardiovascular Interventions; Member of European Association for Cardiovascular Prevention and Rehabilitation, Member of W.G. on Hypertension & the Heart of the ESC.

He is current Editor-in-Chief of Biological Markers and Guided Therapy; Diabetes Research and Treatment; J Stem Cell & Regenerative Biology; Co-Editor "BBA Clinical" and “Current issues of pharmaceutical and medical science and practice”. He has published more than 1000 papers in international reputed journals and authored 57 books/chapters.

His research interest includes the fundamental study of biological markers of cardiovascular and metabolic diseases, heart failure, diabetes mellitus, obesity, endothelial dysfunction, microvesicles, stem cells, the implementation of visualization procedures and percutaneous cardiovascular interventions, the development of cardiovascular prevention and rehabilitation, especially in the field affected heart failure and coronary artery disease, improving knowledge in vascular biology and regenerative medicine.

Leonardo Roever, MHS, PhD
Department of Clinical Research, Federal University of Uberlândia, Uberlândia, Brazil.

Dr. Roever was graduated in 2002 and he had his specialization in Unifesp in 2003. He was granted Master’s Degree in 2008 and PhD in 2019 in Health Sciences from the Federal University of Uberlândia, Brazil. Dr. Roever is currently working at the Department of Clinical Research, Federal University of Uberlandia, Brazil.

Dr. Roever has experience in health care, with emphasis in Clinical Research acting on the following topics: evidence based medicine and practice, atherosclerosis, ectopic adipositopathy, coronary diseases, clinical epidemiology, cardiovascular prevention, hypertension, arrhythmia, diabetes and sports injuries.

Dr. Roever has published more than 200 articles on international peer-reviewed journals, including high-impact journals such as The Lancet, The Lancet Neurology and British Medical Journal. He has authored/co-authored 21 abstracts in conference proceedings, 1 international E-book, and 2 international book chapter. He works as editorial board member of 8 scientific journals and reviewer of numbers of journals.

Series outline:

  1. Biomarkers for subtle myocardial dysfunction in type 1 diabetes mellitus
  2. Periodontal Disease in Diabetes Mellitus: the role of biomarkers
  3. Polyphenol supplementations in diabetics: an impact on cardiac biomarkers
  4. Biomarkers of adipose tissue dysfunction in children and adolescent
  5. Heart failure among patients with prediabetes and type 2 diabetes mellitus: diagnostic and predictive biomarkers
  6. Circulating non-coding RNAs: the novel biomarker of diabetes-related complications
  7. Umbilical cord blood-derived mesenchymal stem cells: utility in patients with diabetes mellitus
  8. Genetic predictive risk score in diabetics
  9. Biomarker-based predictive models in diabetics: challenging and perspectives
  10. Coronary intervention in STEMI patients with type 2 diabetes mellitus: risk stratification with biomarkers
  11. Cardiac biomarkers in children with diabetes mellitus
  12. Extracellular vesicles as predictors of diabetes-related clinical outcomes
  13. Biomarkers of inflammation in patients with diabetes mellitus
  14. Biomarkers of thromboembolism in diabetics

Disclosure:
The series “Biological Markers of Diabetes Mellitus” was commissioned by the editorial office, Journal of Laboratory and Precision Medicine without any sponsorship or funding. Alexander E. Berezin and Leonardo Roever are serving as the unpaid Guest Editors for the series.